1. Home
  2. ASG vs SLN Comparison

ASG vs SLN Comparison

Compare ASG & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty All-Star Growth Fund Inc.

ASG

Liberty All-Star Growth Fund Inc.

HOLD

Current Price

$5.42

Market Cap

341.5M

Sector

Finance

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$9.55

Market Cap

300.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASG
SLN
Founded
N/A
1994
Country
United States
United Kingdom
Employees
N/A
88
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.5M
300.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ASG
SLN
Price
$5.42
$9.55
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$42.60
AVG Volume (30 Days)
189.7K
627.9K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.55
$4.19
52 Week High
$5.69
$11.06

Technical Indicators

Market Signals
Indicator
ASG
SLN
Relative Strength Index (RSI) 54.00 58.59
Support Level $5.39 $5.87
Resistance Level $5.57 $11.06
Average True Range (ATR) 0.09 0.89
MACD -0.01 -0.12
Stochastic Oscillator 57.45 60.33

Price Performance

Historical Comparison
ASG
SLN

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company's portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: